Sanofi en Astra-Zeneca winnen EU-goedkeuring voor preventie van RSV bij kinderen
The European Medicines Agency has recommended the antibody nirsevimab for a marketing authorization in the European Union. This means that, when the European Commission accepts this recommendation, the antibody can be used in the EU for the prevention of Respiratory...